SHP503-803: Drug Utilization Study with Intuniv® in Australia

28/04/2021
14/03/2024
EU PAS number:
EUPAS40684
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

SHP503-803- protocol-original-redact

English (758.68 KB - PDF) View document
Study results
Study results

SHP503-803-clinical-study-report-redact

English (732.02 KB - PDF) View document
Study report
Other information